Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-06-23
1979-05-15
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546 62, A61K 31445, C07D49104
Patent
active
041548361
ABSTRACT:
The invention relates to novel dibenzo[1,2;5,6]cyclohepta pyridine or -pyrrole derivatives, dibenzo[2,3;6,7]oxepino pyridine or pyrrole derivatives, dibenzo[2,3;6,7]thiepino pyridine or pyrrole derivatives and dibenzo[b,f]pyrido or pyrrolo azepine derivatives of general formula: ##STR1## as well as the pharmaceutically acceptable salts and nitrogen oxides thereof, wherein
REFERENCES:
patent: 3636045 (1972-01-01), Blattner et al.
patent: 3726897 (1973-04-01), Schindler
patent: 3773940 (1973-11-01), Schindler
patent: 4002632 (1977-01-01), VAN DER Burg
Smrz, R., et al., Coll. Czech. Chem. Commun., 1976, 41(11), pp. 3420-3436 [Chemical Abstracts, 86:189679t(1977)].
Akzona Incorporated
Falk Robert H.
Ford John M.
Schwartz Richard A.
Wendel Charles A.
LandOfFree
Tension reducing 1,2,3,4,4a,13b-hexahydro-dibenz[2,3;6,7]oxepino does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tension reducing 1,2,3,4,4a,13b-hexahydro-dibenz[2,3;6,7]oxepino, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tension reducing 1,2,3,4,4a,13b-hexahydro-dibenz[2,3;6,7]oxepino will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097328